Leading SPAC Parallel Scraps $1.9 billion Merger Deal with Ceres Corp.

0.9 min readPublished On: October 3rd, 2021By

TORONTO–Ceres Acquisition Corp. (NEO: CERE.U, CERE.WT; OTCQX: CERAF) announced a ”mutually agreed” termination, effective immediately, of its Business Combination Agreement dated February 21, 2021 with SH Parent, Inc.

Chewing gum heir William “Beau” Wrigley Jr.’s cannabis multi-state operator, Parallel, which does business as Surterra Wellness in some states, and music mogul “Scooter” Braun’s Ceres Acquisition Corp. have called off their $1.9 billion blockbuster merger.

The companies didn’t provide a reason for terminating the merger, which would have allowed the resulting company to go public by taking on Ceres’ listing on Canada’s NEO Exchange. which does business as Surterra Wellness in some states

But Reuters reported that “several investors had lost confidence in Parallel’s ability to deliver on lofty financial projections it provided in February when the merger was announced.”

Reporting in MJBizDaily suggests the collapse of the deal to take Atlanta-based Parallel public by Ceres, a special purpose acquisition company in the Los Angeles area, also might reflect a cooling of SPAC activity in recent months in the wake of greater regulatory oversight of the investment vehicles.

Highly Capitalized Copyright ©2021 All Rights Reserved.

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Ayr Wellness

Ayr Wellness Brings Cannabis Brand LIT To Massachusetts

August 4th, 2022|

MIAMI - Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a U.S. multi-state cannabis operator, announced that it has expanded its extensive branded-product portfolio with the flower brand, LIT. LIT originally launched in Nevada, produced by ...

PharmaCielo Announces First Shipment to Mexican Joint Venture Partner

August 4th, 2022|

TORONTO and RIONEGRO, Colombia–PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S.,  today announced its first shipment of ...